RPTUAS Scheme (Revamped Pharmaceutical Technology Upgradation Assistance Scheme)

The RPTUAS scheme supports existing pharmaceutical manufacturing units in upgrading their facilities to meet revised Schedule‑M standards and WHO‑GMP certification requirements. The objective is to strengthen quality compliance and improve the competitiveness of pharmaceutical companies.

Key Benefits

Government Scheme

Key Benefits

Capital subsidy based on annual turnover

Maximum subsidy ₹2 Crore

Subsidy Slab

Turnover Subsidy
₹1 – 50 Cr
Small enterprises
20%
₹50 – 250 Cr
Medium enterprises
15%
₹250 – 500 Cr
Large enterprises
10%

Eligible Projects

Existing pharma units

Turnover below ₹500 Cr

Eligible Investments

Utilities (HVAC, water, Steam)

Clean Room Facility

Testing Lab, Stability Chamber

Effluent treatment/waste Management

Production Equipment

Consultation/certification Express

Any other item approved by the Technical Committee

Process

01

Online application with Gap Analysis

02

PMC evaluation

03

First instalment after Revised Schedule M (50%)

04

Final instalment after WHO-GMP certification (50%)

How We Can Help

Review of your unit’s turnover and activity to ensure eligibility

Assessment of investments made post 01.01.2024 to ensure they meet the scheme's criteria.

Preparation of necessary forms and supporting documents.

Assistance in preparing the Gap Analysis Report.

Coordination with the Project Management Consultant (PMC) for review and recommendation.

Liaising with the Scheme Steering Committee (SSC) for approval